Influence of plasma immunoglobulin level on antibody synthesis

In previous experimental animal studies it has been demonstrated that antibody depletion is not followed by increased antibody synthesis. To assess whether these results are conferrable to antibody-depleted humans, we measured free light chains (flcs) as markers of current antibody synthesis in 8 pa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood 2002-07, Vol.100 (1), p.353-355
Hauptverfasser: Goldammer, Andreas, Derfler, Kurt, Herkner, Kurt, Bradwell, Arthur R., Hörl, Walter H., Haas, Martin
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 355
container_issue 1
container_start_page 353
container_title Blood
container_volume 100
creator Goldammer, Andreas
Derfler, Kurt
Herkner, Kurt
Bradwell, Arthur R.
Hörl, Walter H.
Haas, Martin
description In previous experimental animal studies it has been demonstrated that antibody depletion is not followed by increased antibody synthesis. To assess whether these results are conferrable to antibody-depleted humans, we measured free light chains (flcs) as markers of current antibody synthesis in 8 patients treated with immunoadsorption (IA) therapy. Specific and bulk immunoglobulin levels were obtained simultaneously. The mean serum flc concentration increased to the preapheresis value within 1 day and remained unchanged thereafter. Total immunoglobulin G (IgG) and specific antibody concentrations increased to pretreatment values in 88% and 43% of the patients, respectively, and remained below the original values in the others. In conclusion, the lack of increased flc synthesis after IA confirms the absence of a feedback mechanism regulating antibody synthesis. The restoration of serum IgG levels after IA, therefore, does not result from increased antibody synthesis but is probably related to changes of catabolism and immunoglobulin backflow.
doi_str_mv 10.1182/blood-2002-01-0128
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71831407</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006497120600143</els_id><sourcerecordid>71831407</sourcerecordid><originalsourceid>FETCH-LOGICAL-c426t-bfd06919f8b2433bb26d62087db107bed3c06593e1ac1d97c932c1ba7d4210bc3</originalsourceid><addsrcrecordid>eNp9kE1LxDAQhoMo7vrxBzxIL3qrziRt04IIIn6B4EXPIV_VSJqsTbuw_96uu7A3YWBgeN6X4SHkDOEKsabXysdocgpAc8BpaL1H5ljSOp9OsE_mAFDlRcNxRo5S-gbAgtHykMyQAgcoYU5uX0LrRxu0zWKbLbxMncxc140hfvqoRu9C5u3S-iyGTIbBqWhWWVqF4csml07IQSt9sqfbfUw-Hh_e75_z17enl_u711wXtBpy1RqoGmzaWtGCMaVoZSoKNTcKgStrmIaqbJhFqdE0XDeMalSSm4IiKM2OyeWmd9HHn9GmQXQuaeu9DDaOSXCsGRbAJ5BuQN3HlHrbikXvOtmvBIJYWxN_1sTamgAUa2tT6HzbPqrOml1kq2kCLraATFr6tpdBu7TjGC8pLXDibjacnVwsne1F0m4t17je6kGY6P774xcLdIpL</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71831407</pqid></control><display><type>article</type><title>Influence of plasma immunoglobulin level on antibody synthesis</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Goldammer, Andreas ; Derfler, Kurt ; Herkner, Kurt ; Bradwell, Arthur R. ; Hörl, Walter H. ; Haas, Martin</creator><creatorcontrib>Goldammer, Andreas ; Derfler, Kurt ; Herkner, Kurt ; Bradwell, Arthur R. ; Hörl, Walter H. ; Haas, Martin</creatorcontrib><description>In previous experimental animal studies it has been demonstrated that antibody depletion is not followed by increased antibody synthesis. To assess whether these results are conferrable to antibody-depleted humans, we measured free light chains (flcs) as markers of current antibody synthesis in 8 patients treated with immunoadsorption (IA) therapy. Specific and bulk immunoglobulin levels were obtained simultaneously. The mean serum flc concentration increased to the preapheresis value within 1 day and remained unchanged thereafter. Total immunoglobulin G (IgG) and specific antibody concentrations increased to pretreatment values in 88% and 43% of the patients, respectively, and remained below the original values in the others. In conclusion, the lack of increased flc synthesis after IA confirms the absence of a feedback mechanism regulating antibody synthesis. The restoration of serum IgG levels after IA, therefore, does not result from increased antibody synthesis but is probably related to changes of catabolism and immunoglobulin backflow.</description><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood-2002-01-0128</identifier><identifier>PMID: 12070050</identifier><language>eng</language><publisher>Washington, DC: Elsevier Inc</publisher><subject>Adult ; Aged ; Antibody Formation - drug effects ; Autoimmune Diseases - blood ; Autoimmune Diseases - drug therapy ; Biological and medical sciences ; Feedback, Physiological - immunology ; Female ; Fundamental and applied biological sciences. Psychology ; Fundamental immunology ; Humans ; Immunobiology ; Immunoglobulin kappa-Chains - blood ; Immunoglobulins - blood ; Immunoglobulins - pharmacology ; Immunopathology ; Immunosuppressive Agents - administration &amp; dosage ; Immunotherapy (general aspects) ; Male ; Medical sciences ; Middle Aged ; Modulation of the immune response (stimulation, suppression)</subject><ispartof>Blood, 2002-07, Vol.100 (1), p.353-355</ispartof><rights>2002 American Society of Hematology</rights><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c426t-bfd06919f8b2433bb26d62087db107bed3c06593e1ac1d97c932c1ba7d4210bc3</citedby><cites>FETCH-LOGICAL-c426t-bfd06919f8b2433bb26d62087db107bed3c06593e1ac1d97c932c1ba7d4210bc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=13752241$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12070050$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Goldammer, Andreas</creatorcontrib><creatorcontrib>Derfler, Kurt</creatorcontrib><creatorcontrib>Herkner, Kurt</creatorcontrib><creatorcontrib>Bradwell, Arthur R.</creatorcontrib><creatorcontrib>Hörl, Walter H.</creatorcontrib><creatorcontrib>Haas, Martin</creatorcontrib><title>Influence of plasma immunoglobulin level on antibody synthesis</title><title>Blood</title><addtitle>Blood</addtitle><description>In previous experimental animal studies it has been demonstrated that antibody depletion is not followed by increased antibody synthesis. To assess whether these results are conferrable to antibody-depleted humans, we measured free light chains (flcs) as markers of current antibody synthesis in 8 patients treated with immunoadsorption (IA) therapy. Specific and bulk immunoglobulin levels were obtained simultaneously. The mean serum flc concentration increased to the preapheresis value within 1 day and remained unchanged thereafter. Total immunoglobulin G (IgG) and specific antibody concentrations increased to pretreatment values in 88% and 43% of the patients, respectively, and remained below the original values in the others. In conclusion, the lack of increased flc synthesis after IA confirms the absence of a feedback mechanism regulating antibody synthesis. The restoration of serum IgG levels after IA, therefore, does not result from increased antibody synthesis but is probably related to changes of catabolism and immunoglobulin backflow.</description><subject>Adult</subject><subject>Aged</subject><subject>Antibody Formation - drug effects</subject><subject>Autoimmune Diseases - blood</subject><subject>Autoimmune Diseases - drug therapy</subject><subject>Biological and medical sciences</subject><subject>Feedback, Physiological - immunology</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Fundamental immunology</subject><subject>Humans</subject><subject>Immunobiology</subject><subject>Immunoglobulin kappa-Chains - blood</subject><subject>Immunoglobulins - blood</subject><subject>Immunoglobulins - pharmacology</subject><subject>Immunopathology</subject><subject>Immunosuppressive Agents - administration &amp; dosage</subject><subject>Immunotherapy (general aspects)</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Modulation of the immune response (stimulation, suppression)</subject><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1LxDAQhoMo7vrxBzxIL3qrziRt04IIIn6B4EXPIV_VSJqsTbuw_96uu7A3YWBgeN6X4SHkDOEKsabXysdocgpAc8BpaL1H5ljSOp9OsE_mAFDlRcNxRo5S-gbAgtHykMyQAgcoYU5uX0LrRxu0zWKbLbxMncxc140hfvqoRu9C5u3S-iyGTIbBqWhWWVqF4csml07IQSt9sqfbfUw-Hh_e75_z17enl_u711wXtBpy1RqoGmzaWtGCMaVoZSoKNTcKgStrmIaqbJhFqdE0XDeMalSSm4IiKM2OyeWmd9HHn9GmQXQuaeu9DDaOSXCsGRbAJ5BuQN3HlHrbikXvOtmvBIJYWxN_1sTamgAUa2tT6HzbPqrOml1kq2kCLraATFr6tpdBu7TjGC8pLXDibjacnVwsne1F0m4t17je6kGY6P774xcLdIpL</recordid><startdate>20020701</startdate><enddate>20020701</enddate><creator>Goldammer, Andreas</creator><creator>Derfler, Kurt</creator><creator>Herkner, Kurt</creator><creator>Bradwell, Arthur R.</creator><creator>Hörl, Walter H.</creator><creator>Haas, Martin</creator><general>Elsevier Inc</general><general>The Americain Society of Hematology</general><scope>6I.</scope><scope>AAFTH</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20020701</creationdate><title>Influence of plasma immunoglobulin level on antibody synthesis</title><author>Goldammer, Andreas ; Derfler, Kurt ; Herkner, Kurt ; Bradwell, Arthur R. ; Hörl, Walter H. ; Haas, Martin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c426t-bfd06919f8b2433bb26d62087db107bed3c06593e1ac1d97c932c1ba7d4210bc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Antibody Formation - drug effects</topic><topic>Autoimmune Diseases - blood</topic><topic>Autoimmune Diseases - drug therapy</topic><topic>Biological and medical sciences</topic><topic>Feedback, Physiological - immunology</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Fundamental immunology</topic><topic>Humans</topic><topic>Immunobiology</topic><topic>Immunoglobulin kappa-Chains - blood</topic><topic>Immunoglobulins - blood</topic><topic>Immunoglobulins - pharmacology</topic><topic>Immunopathology</topic><topic>Immunosuppressive Agents - administration &amp; dosage</topic><topic>Immunotherapy (general aspects)</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Modulation of the immune response (stimulation, suppression)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Goldammer, Andreas</creatorcontrib><creatorcontrib>Derfler, Kurt</creatorcontrib><creatorcontrib>Herkner, Kurt</creatorcontrib><creatorcontrib>Bradwell, Arthur R.</creatorcontrib><creatorcontrib>Hörl, Walter H.</creatorcontrib><creatorcontrib>Haas, Martin</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Goldammer, Andreas</au><au>Derfler, Kurt</au><au>Herkner, Kurt</au><au>Bradwell, Arthur R.</au><au>Hörl, Walter H.</au><au>Haas, Martin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Influence of plasma immunoglobulin level on antibody synthesis</atitle><jtitle>Blood</jtitle><addtitle>Blood</addtitle><date>2002-07-01</date><risdate>2002</risdate><volume>100</volume><issue>1</issue><spage>353</spage><epage>355</epage><pages>353-355</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><abstract>In previous experimental animal studies it has been demonstrated that antibody depletion is not followed by increased antibody synthesis. To assess whether these results are conferrable to antibody-depleted humans, we measured free light chains (flcs) as markers of current antibody synthesis in 8 patients treated with immunoadsorption (IA) therapy. Specific and bulk immunoglobulin levels were obtained simultaneously. The mean serum flc concentration increased to the preapheresis value within 1 day and remained unchanged thereafter. Total immunoglobulin G (IgG) and specific antibody concentrations increased to pretreatment values in 88% and 43% of the patients, respectively, and remained below the original values in the others. In conclusion, the lack of increased flc synthesis after IA confirms the absence of a feedback mechanism regulating antibody synthesis. The restoration of serum IgG levels after IA, therefore, does not result from increased antibody synthesis but is probably related to changes of catabolism and immunoglobulin backflow.</abstract><cop>Washington, DC</cop><pub>Elsevier Inc</pub><pmid>12070050</pmid><doi>10.1182/blood-2002-01-0128</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0006-4971
ispartof Blood, 2002-07, Vol.100 (1), p.353-355
issn 0006-4971
1528-0020
language eng
recordid cdi_proquest_miscellaneous_71831407
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Adult
Aged
Antibody Formation - drug effects
Autoimmune Diseases - blood
Autoimmune Diseases - drug therapy
Biological and medical sciences
Feedback, Physiological - immunology
Female
Fundamental and applied biological sciences. Psychology
Fundamental immunology
Humans
Immunobiology
Immunoglobulin kappa-Chains - blood
Immunoglobulins - blood
Immunoglobulins - pharmacology
Immunopathology
Immunosuppressive Agents - administration & dosage
Immunotherapy (general aspects)
Male
Medical sciences
Middle Aged
Modulation of the immune response (stimulation, suppression)
title Influence of plasma immunoglobulin level on antibody synthesis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T16%3A50%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Influence%20of%20plasma%20immunoglobulin%20level%20on%20antibody%20synthesis&rft.jtitle=Blood&rft.au=Goldammer,%20Andreas&rft.date=2002-07-01&rft.volume=100&rft.issue=1&rft.spage=353&rft.epage=355&rft.pages=353-355&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood-2002-01-0128&rft_dat=%3Cproquest_cross%3E71831407%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71831407&rft_id=info:pmid/12070050&rft_els_id=S0006497120600143&rfr_iscdi=true